2018
DOI: 10.1002/ame2.12039
|View full text |Cite
|
Sign up to set email alerts
|

Anti‐leukemic and anti‐angiogenic effects of d‐Limonene on K562‐implanted C57BL/6 mice and the chick chorioallantoic membrane model

Abstract: Background d ‐Limonene, a monoterpene from citrus fruit has been found to have chemopreventive and chemotherapeutic activities in various types of cancers. In this study, we evaluated the in vivo effect of d ‐Limonene on a K562‐induced model of chronic myeloid leukemia ( CML ) in C57 BL /6 mice. Method The tail vein injection model of K562 cells in immunocompromised C57BL/6 m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
12
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 25 publications
0
12
0
Order By: Relevance
“…D-limonene metabolites have been detected in adipose tissue and mammary glands in a high concentration, although it has low toxicity [101]. This compound shows different pharmacological properties, which include anti-inflammatory, gastro-protective, anti-nociceptive, anti-tumor, and neuroprotective [102][103][104]. A recent study has demonstrated D-limonene anti-tumor activity (i.e., tumor cells decreased in proliferation and growth) in an animal model of chronic myeloid leukemia [102].…”
Section: D-limonenementioning
confidence: 99%
See 1 more Smart Citation
“…D-limonene metabolites have been detected in adipose tissue and mammary glands in a high concentration, although it has low toxicity [101]. This compound shows different pharmacological properties, which include anti-inflammatory, gastro-protective, anti-nociceptive, anti-tumor, and neuroprotective [102][103][104]. A recent study has demonstrated D-limonene anti-tumor activity (i.e., tumor cells decreased in proliferation and growth) in an animal model of chronic myeloid leukemia [102].…”
Section: D-limonenementioning
confidence: 99%
“…This compound shows different pharmacological properties, which include anti-inflammatory, gastro-protective, anti-nociceptive, anti-tumor, and neuroprotective [102][103][104]. A recent study has demonstrated D-limonene anti-tumor activity (i.e., tumor cells decreased in proliferation and growth) in an animal model of chronic myeloid leukemia [102]. Moreover, D-limonene also showed anti-inflammatory activity by inhibiting pro-inflammatory mediators, leukocyte migration, and vascular permeability [105].…”
Section: D-limonenementioning
confidence: 99%
“…Several experiments have been carried out for demonstrating the anticancer property of limonene. Limonene has shown anti-leukemic and anti-angiogenic property against chronic myeloid leukemia (CML) (Shah et al, 2018). CML causes rapid increase in the counts of white blood cell (WBC), lymphocytes (LY) and neutrophils (NE) whereas reduces the hemoglobin (Hb) content and number of red blood cells (RBC) (Shah et al, 2018).…”
Section: Anti-cancer Activitymentioning
confidence: 99%
“…Limonene has shown anti-leukemic and anti-angiogenic property against chronic myeloid leukemia (CML) (Shah et al, 2018). CML causes rapid increase in the counts of white blood cell (WBC), lymphocytes (LY) and neutrophils (NE) whereas reduces the hemoglobin (Hb) content and number of red blood cells (RBC) (Shah et al, 2018). Treatment of murine models of CML with d-limonenedecreased the counts WBC, LY and NE and increased the Hb content and RBC counts.…”
Section: Anti-cancer Activitymentioning
confidence: 99%
“…[ 2 ] Previous studies have reported that D-Limonene is cytotoxic to cancer cells but not to hepatocytes. [ 3 ]…”
Section: Introductionmentioning
confidence: 99%